/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

KENVUE INC.

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$16.87 0.0065(0.65%) KVUE at 04 Dec 2025 04:36 PM Household & Personal Products
Lowest Today 16.75
Highest Today 17.05
Today’s Open 16.95
Prev. Close 16.86
52 Week High 24.41
52 Week Low 13.85
Day’s Range: Low 16.75 High 17.05
52-Week Range: Low 13.85 High 24.41
1 day return -
1 Week return -2.02
1 month return +6.22
3 month return -17.3
6 month return -21.7
1 year return -26.75
3 year return -
5 year return -
10 year return -

Institutional Holdings

Market Status

Strong Buy: 3

Buy: 2

Hold: 14

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 32355.52 M

PB Ratio 3.1257

PE Ratio 22.7838

Enterprise Value 41209.17 M

Total Assets 25601.00 M

Volume 41596405

Company Financials

Annual Revenue FY24:15455000000 15455.0M, FY23:15443000000 15443.0M, FY22:14950000000 14950.0M, FY21:15054000000 15054.0M, FY20:14467000000 14467.0M

Annual Profit FY24:8959000000 8959.0M, FY23:8612000000 8612.0M, FY22:8285000000 8285.0M, FY21:8419000000 8419.0M, FY20:7848000000 7848.0M

Annual Net worth FY24:1030000000 1030.0M, FY23:1664000000 1664.0M, FY22:2087000000 2087.0M, FY21:2031000000 2031.0M, FY20:-879000000 -879.0M

Quarterly Revenue Q3/2025:3764000000 3764.0M, Q2/2025:3839000000 3839.0M, Q1/2025:3741000000 3741.0M, Q4/2024:3662000000 3662.0M, Q3/2024:3899000000 3899.0M

Quarterly Profit Q3/2025:2226000000 2226.0M, Q2/2025:2261000000 2261.0M, Q1/2025:2168000000 2168.0M, Q4/2024:2070000000 2070.0M, Q3/2024:2282000000 2282.0M

Quarterly Net worth Q3/2025:398000000 398.0M, Q2/2025:420000000 420.0M, Q1/2025:322000000 322.0M, Q4/2024:293000000 293.0M, Q3/2024:383000000 383.0M

Fund house & investment objective

Company Information Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Organisation Household & Personal Products

Employees 22000

Industry Household & Personal Products

CEO Mr. Kirk L. Perry

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow